DOSSIER · UPDATED 18 NOV 2025

Alume Biosciences

The mission of Alume Biosciences is to make its proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit.

alumebiosciences.com ↗Claim this profile

Founded: 2017
Headcount: 17
Open roles: 0
Last raised: Series B · $13M

SECTION I · THE BRIEF

Inside Alume Biosciences

Brief #96644Updated 18 NOV 2025SAN DIEGOMEDICAL ORGANIZATIONSSERIES B

Employbl Dossier

Alume Biosciences

The mission of Alume Biosciences is to make its proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit.

Founded: 2017
Headcount: 17
Open roles: 0
Last raised: Series B · $13M

Section II · Premium ProfileMembers only

01Engineering interview process at Alume BiosciencesLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Alume Biosciences brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Quyen Nguyen

Brett Berman

Chrysa Mineo

OPEN ROLES

Hiring at Alume Biosciences

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $27,672,024

Alume Biosciences Funding Rounds

Series B
$13,000,000
Jan 10, 2023
Series B
$13,000,000
Jan 9, 2023
Grant
$3,400,000
Sep 9, 2022
Grant
$3,400,000
Sep 8, 2022
Grant Investors
National Institute of Neurological Disorders and Stroke (NINDS)
Series A
$5,500,000
May 1, 2020
Series A
$5,500,000
Apr 30, 2020
Series A Investors
Chrysa Mineo
Daniel Bradbury
Series Unknown
$5,772,023
Jun 28, 2019
Series Unknown
$5,772,023
Jun 27, 2019